Valuation Caplin Point Laboratories Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 14:05:07 27/07/2026 +03			5-day change	1st Jan Change
2,621.40 ^INR	+6.25%		+0.28%	+42.61%

05-15	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
05-14	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	199,390	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	30.99%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	199,390	199,390	199,390
Change	-	68.55%	-12.11%	120.88%	52.16%	30.99%	0%	0%
P/E	12.7x	17.3x	12.1x	22x	28.5x	17.9x	28x	24.5x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.53x	4.12x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.8x	1.7x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	8.01x	7.11x
EV / Revenue	0x	0x	0x	0x	0x	9.37x	8.01x	7.11x
EV / EBITDA	0x	0x	0x	0x	0x	26.9x	23.2x	20.3x
EV / EBIT	0x	0x	0x	-	0x	25.6x	21.4x	18.5x
EV / FCF	0x	0x	0x	0x	0x	52.5x	36.2x	36.8x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	2.76%	2.71%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.15%	0.15%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	93.8	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.26%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	24,880	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,604	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,128	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,623.15	2,623.15	2,623.15
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	5/6/21 A	5/12/22 A	5/27/23 A	5/16/24 A	5/15/25 A	5/14/26 A	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.57x	6.72x	23.2x	0.82%	48.36B
OTSUKA HOLDINGS CO., LTD.	18.36x	2.08x	9.81x	1.3%	35.8B
CIPLA LIMITED	27.36x	3.33x	17.24x	0.9%	11.83B
ZYDUS LIFESCIENCES LIMITED	26.28x	3.88x	15.8x	0.6%	11.48B
KRKA, D. D.	19.15x	3.35x	12.02x	3.48%	9.01B
ONO PHARMACEUTICAL CO., LTD.	16.13x	2.08x	6.99x	3.22%	6.99B
GEDEON RICHTER	8.12x	1.9x	4.97x	5.34%	6.7B
GLENMARK PHARMACEUTICALS LIMITED	33.27x	3.78x	16.1x	0.24%	6.42B
Average	23.03x	3.39x	13.27x	1.99%	17.08B
Weighted average by Cap.	26.04x	4.14x	15.76x	1.43%